Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Peacock

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Social Science & Medicine (1982)|July 2, 2016
High performance in healthcare priority setting and resource allocation: A literature- and case study-based framework in the Canadian contextNeale Smith, Craig Mitton, William Hall, et al.
Health and Quality of Life Outcomes|December 3, 2013
Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6DPaulos Teckle, Helen McTaggart-Cowan, Kim Van der Hoek, et al.
Health and Quality of Life Outcomes|November 30, 2011
The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severitiesPaulos Teckle, Stuart Peacock, Helen McTaggart-Cowan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2012
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, CanadaLindsay Hedden, Hagen Kennecke, Diego Villa, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Risk of Anxiety and Depression after Diagnosis of Young-Onset Colorectal Cancer: A Population-Based Cohort StudyAlyssa Howren, Eric C Sayre, Vicki Cheng, et al.
Journal of Cancer Policy|July 20, 2024
Real-world cost-effectiveness of panel-based genomic testing to inform therapeutic decisions for metastatic colorectal cancerReka E Pataky, Deirdre Weymann, Ian Bosdet, et al.
Patient Education and Counseling|December 24, 2018
Communicating uncertainty in cancer prognosis: A review of web-based prognostic toolsMark Harrison, Paul K J Han, Borsika Rabin, et al.
Familial Cancer|April 10, 2026
Factors influencing public willingness to participate in population-based hereditary cancer genetic testing: a qualitative study of public preferencesDiego R Sanchez-Vazquez, Jonathan Avery, Whitney Qualls, et al.
International Journal of Technology Assessment in Health Care|February 9, 2019
How Procurement Judges The Value of Medical Technologies: A Review of Healthcare TendersFiona A Miller, Pascale Lehoux, Stuart Peacock, et al.
International Journal of Cancer|January 21, 2014
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, CanadaReka Pataky, Roman Gulati, Ruth Etzioni, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Social Science & Medicine (1982)|July 2, 2016
High performance in healthcare priority setting and resource allocation: A literature- and case study-based framework in the Canadian contextNeale Smith, Craig Mitton, William Hall, et al.
Health and Quality of Life Outcomes|December 3, 2013
Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6DPaulos Teckle, Helen McTaggart-Cowan, Kim Van der Hoek, et al.
Health and Quality of Life Outcomes|November 30, 2011
The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severitiesPaulos Teckle, Stuart Peacock, Helen McTaggart-Cowan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2012
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, CanadaLindsay Hedden, Hagen Kennecke, Diego Villa, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Risk of Anxiety and Depression after Diagnosis of Young-Onset Colorectal Cancer: A Population-Based Cohort StudyAlyssa Howren, Eric C Sayre, Vicki Cheng, et al.
Journal of Cancer Policy|July 20, 2024
Real-world cost-effectiveness of panel-based genomic testing to inform therapeutic decisions for metastatic colorectal cancerReka E Pataky, Deirdre Weymann, Ian Bosdet, et al.
Patient Education and Counseling|December 24, 2018
Communicating uncertainty in cancer prognosis: A review of web-based prognostic toolsMark Harrison, Paul K J Han, Borsika Rabin, et al.
Familial Cancer|April 10, 2026
Factors influencing public willingness to participate in population-based hereditary cancer genetic testing: a qualitative study of public preferencesDiego R Sanchez-Vazquez, Jonathan Avery, Whitney Qualls, et al.
International Journal of Technology Assessment in Health Care|February 9, 2019
How Procurement Judges The Value of Medical Technologies: A Review of Healthcare TendersFiona A Miller, Pascale Lehoux, Stuart Peacock, et al.
International Journal of Cancer|January 21, 2014
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, CanadaReka Pataky, Roman Gulati, Ruth Etzioni, et al.
Pageof 14